type here...

CATEGORIES

Research Critique

LATEST

12Page 2 of 2

TRENDING

EDITORS CHOICE

Is the New York Times a Shill for Promoters of Psychedelics?

James Coyne -
Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should be able to expect.

Perhaps, A Braver New World

John Nosta -
The drip, drip, drip of innovation might just be a myth. Change commonly occurs as a punctuated reality that’s a function of converging events...

Gabor Maté’s Bizarre Ideas on Connections Between Stress and Disease

James Coyne -
Gabor Maté’s issues are with evidence, not the West and with public health, not medicine, but who takes him seriously? Lots of otherwise smart people seem to…or maybe not.

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

James Coyne -
The largest number of authors (12) are with MAPS. The for-profit corporation will manage sales for prescription MDMA when it is approved by the FDA

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories